Citation 60029

VAN BEEK,TA: VERPOORTE,R: BAERHEIM-SVENDSEN,A: FOKKENS,R:. (1985). ANTIMICROBIALLY ACTIVE ALKALOIDS FROM TABERNAEMONTANA CHIPPII.. 48(3)

Citation Details

Title	ANTIMICROBIALLY ACTIVE ALKALOIDS FROM TABERNAEMONTANA CHIPPII.
Authors	VAN BEEK,TA: VERPOORTE,R: BAERHEIM-SVENDSEN,A: FOKKENS,R:
Year	1985
Volume	48
Issue	3

Summary

Year: 1985

Journal: Unknown

Organisms and Their Experiments (1)

Tabernaemontana chippii (APOCYNACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OF	SITSIRIKINE,ISO:	None
2	Not specified	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OF	SITSIRIKINE,ISO: 16-EPI:	None
3	Not specified	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OFPMR SPECTRUM REPORTED	MACUSINE B,NOR:	None
4	Not specified	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OFPMR SPECTRUM REPORTED	PERICYCLIVINE	None
5	Not specified	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OF	AFFININE,16-EPI:	None
6	Not specified	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OFPMR SPECTRUM REPORTED	VOBASINE	None
7	Not specified	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OFPMR SPECTRUM REPORTED	TABERPSYCHINE	None
8	Not specified	VOUCHER SPECIMEN REPORTED FORUV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTED	VOBASINOL	None
9	Not specified	VOUCHER SPECIMEN REPORTED FORUV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREFIELD DESORPTION MASS SPECTRUM OF	TABERNAEMONTANA CHIPPII ALKALOID D	None
10	Not specified	VOUCHER SPECIMEN REPORTED FORUV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTED	AKUAMMILINE	None
11	Not specified	VOUCHER SPECIMEN REPORTED FORUV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTED	AKUAMMILINE,DEACETYL:	None
12	Not specified	VOUCHER SPECIMEN REPORTED FORUV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTED	PICRALINE	None
13	Not specified	VOUCHER SPECIMEN REPORTED FORUV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDTLC DATA REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	TACRALINE	None
14	Not specified	VOUCHER SPECIMEN REPORTED FORUV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDTLC DATA REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	TACRALINE,DEACETYL:	None
15	Not specified	VOUCHER SPECIMEN REPORTED FORUV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTED	PLEIOCARPAMINE	None
16	Not specified	VOUCHER SPECIMEN REPORTED FORUV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTED	AKUAMMICINE,12-HYDROXY:	None
17	Not specified	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OF	PERICALLINE	None
18	Not specified	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDCD SPECTRUM REPORTED FOR	VOBPARICINE	None
19	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	VOBPARICINE	ACTIVE
20	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	VOBPARICINE	WEAK ACTIVITY
21	Not specified	VOUCHER SPECIMEN REPORTED FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDTLC DATA REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FORFIELD DESORPTION MASS SPECTRUM OF	VOBPARICINE-N(4)-OXIDE	None
22	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	VOBPARICINE-N(4)-OXIDE	ACTIVE
23	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	VOBPARICINE-N(4)-OXIDE	ACTIVE
24	Not specified	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OF	TUBOTAIWINE	None
25	Not specified	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OF	VOAPHYLLINE	None
26	Not specified	VOUCHER SPECIMEN REPORTED FORUV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDTLC DATA REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	TABERNAEMONTANA CHIPPII ALKALOID A	None
27	Not specified	VOUCHER SPECIMEN REPORTED FORUV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	TABERNAEMONTANA CHIPPII ALKALOID C	None
28	Not specified	VOUCHER SPECIMEN REPORTED FORUV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDTLC DATA REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	TABERNAEMONTANA CHIPPII ALKALOID B	None
29	Not specified	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FOR	CONOPHARYNGINE	None
30	Not specified	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORFIELD DESORPTION MASS SPECTRUM OF	CONOPHARYNGINE,3(R)-HYDROXY:	None
31	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CONOPHARYNGINE,3(R)-HYDROXY:	ACTIVE
32	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CONOPHARYNGINE,3(R)-HYDROXY:	ACTIVE
33	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CONOPHARYNGINE,3(R)-HYDROXY:	INACTIVE
34	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CONOPHARYNGINE,3(R)-HYDROXY:	INACTIVE
35	Not specified	VOUCHER SPECIMEN REPORTED FORUV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDTLC DATA REPORTED	CONOPHARYNGINE,3-OXO:	None
36	Not specified	VOUCHER SPECIMEN REPORTED FORUV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDCD SPECTRUM REPORTED FOR	CORONARIDINE	None
37	Not specified	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OFPMR SPECTRUM REPORTEDCD SPECTRUM REPORTED FOR	IBOGALINE	None
38	Not specified	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OFCD SPECTRUM REPORTED FOR	VOACANGINE,ISO:	None
39	Not specified	VOUCHER SPECIMEN REPORTED FORUV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCD SPECTRUM REPORTED FOR	VOACANGINE,ISO: 3(R)-HYDROXY:	None
40	Not specified	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCD SPECTRUM REPORTED FORFIELD DESORPTION MASS SPECTRUM OF	CONODURAMINE	None
41	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CONODURAMINE	ACTIVE
42	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CONODURAMINE	ACTIVE
43	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CONODURAMINE	ACTIVE
44	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CONODURAMINE	WEAK ACTIVITY
45	Not specified	VOUCHER SPECIMEN REPORTED FORUV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR	CONODURAMINE,3(R)-HYDROXY:	None
46	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CONODURAMINE,3(R)-HYDROXY:	ACTIVE
47	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CONODURAMINE,3(R)-HYDROXY:	ACTIVE
48	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CONODURAMINE,3(R)-HYDROXY:	WEAK ACTIVITY
49	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CONODURAMINE,3(R)-HYDROXY:	ACTIVE
50	Not specified	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OFPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDCD SPECTRUM REPORTED FOR	CONODURINE	None
51	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CONODURINE	ACTIVE
52	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CONODURINE	ACTIVE
53	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CONODURINE	ACTIVE
54	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CONODURINE	WEAK ACTIVITY
55	Not specified	VOUCHER SPECIMEN REPORTED FORUV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FORFIELD DESORPTION MASS SPECTRUM OF	CONODURINE,3(R)-HYDROXY:	None
56	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CONODURINE,3(R)-HYDROXY:	ACTIVE
57	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CONODURINE,3(R)-HYDROXY:	ACTIVE
58	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CONODURINE,3(R)-HYDROXY:	WEAK ACTIVITY
59	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CONODURINE,3(R)-HYDROXY:	WEAK ACTIVITY
60	Not specified	VOUCHER SPECIMEN REPORTED FORUV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDTLC DATA REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR	CONODURINE,16-DECARBOMETHOXY: 3(R)-HYDROXY:	None
61	Not specified	VOUCHER SPECIMEN REPORTED FORUV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FORFIELD DESORPTION MASS SPECTRUM OF	VOACAMINE,3(R)-HYDROXY:	None
62	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	VOACAMINE,3(R)-HYDROXY:	ACTIVE
63	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	VOACAMINE,3(R)-HYDROXY:	ACTIVE
64	Not specified	VOUCHER SPECIMEN REPORTED FORUV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDTLC DATA REPORTED	MONOGAGAINE	None
65	Not specified	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OFPMR SPECTRUM REPORTED	CONOPHARYNGINE-HYDROXY-INDOLENINE	None
66	Not specified	VOUCHER SPECIMEN REPORTED FORISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	CONOPHARYNGINE-HYDROXY-INDOLENINE,3(R)-HYDROXY:	None
67	Not specified	VOUCHER SPECIMEN REPORTED FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDTLC DATA REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR	CHIPPIINE	None

Citation 60029

Citation Details

Summary

Organisms and Their Experiments (1)

Tabernaemontana chippii (APOCYNACEAE)

Show SPARQL Queries (1)

Query 1